Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_assertion type Assertion NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_head.
- NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_assertion description "[The United States CF Foundation recently proposed the term cystic fibrosis transmembrane conductance regulator related metabolic syndrome (CRMS) to describe infants with elevated immunoreactive trypsinogen (IRT) on NBS who do not meet diagnostic criteria for CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_provenance.
- NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_assertion evidence source_evidence_literature NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_provenance.
- NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_assertion SIO_000772 21538969 NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_provenance.
- NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_assertion wasDerivedFrom befree-20150227 NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_provenance.
- NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_assertion wasGeneratedBy ECO_0000203 NP592293.RAVEpfDI9DBglfe6Ha60I94PvQt6_FQ4lhqBtY3XCl04c130_provenance.